Target intelligence / Profile preview

ITPRID2 divergent transcript (ITPRID2-DT)

Target
ITPRID2-DT
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

ITPRID2 divergent transcript (ITPRID2-DT) is a long non-coding RNA found on the human genome that originates from the promoter region of the protein-coding ITPRID2 gene. It is classified as a bidirectionally transcribed lncRNA (sometimes called a promoter-divergent transcript). ITPRID2-DT does not encode a protein and is not known to have canonical enzyme, receptor, transporter, or other typical "target" functions. Research on transcription termination mechanisms highlights ITPRID2-DT as a representative locus for studies on proteins that restrict extragenic, non-coding transcription, such as the ZC3H4 complex; ZC3H4 controls early termination of such lncRNAs, preventing their excessive elongation and accumulation[2][5][7][1][3]. There is no evidence supporting a direct connection to diseases or therapeutic relevance at present.

Other names
ITPRID2-DTITPRID2 divergent transcript
02

Biological functions

Transcriptional regulationNon-coding RNA metabolism
03

Disease associations

Other (No known direct roles in major disease categories such as cancer, neurodegeneration, cardiovascular, or inflammation as of the latest literature)

Beyond the preview

Go deeper on ITPRID2 divergent transcript (ITPRID2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITPRID2 divergent transcript (ITPRID2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call